HERON THERAPEUTICS INC's ticker is HRTX and the CUSIP is 427746102. A total of 177 filers reported holding HERON THERAPEUTICS INC in Q2 2019. The put-call ratio across all filers is 1.13 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $78,993 | -27.4% | 76,692 | -18.2% | 0.00% | – |
| Q2 2023 | $108,801 | +12640.2% | 93,794 | -83.4% | 0.00% | – |
| Q1 2023 | $854 | -90.3% | 565,788 | -83.9% | 0.00% | -100.0% |
| Q4 2022 | $8,766 | -99.9% | 3,506,354 | +108.6% | 0.01% | +25.0% |
| Q3 2022 | $7,094,000 | +489.2% | 1,680,966 | +289.4% | 0.00% | – |
| Q2 2022 | $1,204,000 | -82.5% | 431,638 | -64.1% | 0.00% | -100.0% |
| Q1 2022 | $6,880,000 | -25.0% | 1,202,738 | +19.7% | 0.00% | -20.0% |
| Q4 2021 | $9,174,000 | +80.4% | 1,004,798 | +206.6% | 0.01% | +66.7% |
| Q2 2021 | $5,086,000 | -69.8% | 327,721 | -68.5% | 0.00% | -75.0% |
| Q1 2021 | $16,856,000 | +298.1% | 1,039,846 | +419.8% | 0.01% | +300.0% |
| Q4 2020 | $4,234,000 | +39.9% | 200,031 | -2.1% | 0.00% | -25.0% |
| Q3 2020 | $3,027,000 | -49.2% | 204,238 | -59.8% | 0.00% | -69.2% |
| Q1 2020 | $5,962,000 | -64.1% | 507,854 | -28.2% | 0.01% | -38.1% |
| Q4 2019 | $16,627,000 | +58.5% | 707,544 | +24.8% | 0.02% | +23.5% |
| Q3 2019 | $10,488,000 | +61.4% | 566,931 | +62.2% | 0.02% | +70.0% |
| Q2 2019 | $6,500,000 | +311.4% | 349,629 | +440.8% | 0.01% | +400.0% |
| Q1 2019 | $1,580,000 | +20.2% | 64,650 | +55.7% | 0.00% | 0.0% |
| Q3 2018 | $1,315,000 | -81.1% | 41,535 | -76.8% | 0.00% | -77.8% |
| Q2 2018 | $6,968,000 | +22.1% | 179,364 | -43.1% | 0.01% | +12.5% |
| Q4 2017 | $5,705,000 | -4.5% | 315,173 | -14.8% | 0.01% | -11.1% |
| Q3 2017 | $5,973,000 | +155.5% | 369,874 | +119.1% | 0.01% | +125.0% |
| Q2 2017 | $2,338,000 | -30.6% | 168,777 | -34.3% | 0.00% | -42.9% |
| Q4 2016 | $3,368,000 | -11.3% | 257,062 | +28.5% | 0.01% | -22.2% |
| Q1 2016 | $3,798,000 | -84.0% | 200,000 | -73.7% | 0.01% | -80.0% |
| Q2 2015 | $23,686,000 | +140.8% | 760,146 | +12.4% | 0.04% | +150.0% |
| Q1 2015 | $9,838,000 | +293.8% | 676,152 | +172.3% | 0.02% | +260.0% |
| Q4 2014 | $2,498,000 | +49.6% | 248,357 | +23.9% | 0.01% | +25.0% |
| Q3 2014 | $1,670,000 | -36.4% | 200,469 | -5.9% | 0.00% | -42.9% |
| Q2 2014 | $2,624,000 | +9.2% | 213,006 | +23.3% | 0.01% | 0.0% |
| Q1 2014 | $2,402,000 | – | 172,697 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TANG KEVIN C | 760 | $1,900 | 100.00% |
| Velan Capital Investment Management LP | 2,500,000 | $6,250,000 | 5.52% |
| GREAT POINT PARTNERS LLC | 6,360,161 | $15,900,403 | 3.12% |
| Cheyne Capital Management (UK) LLP | 318,008 | $795,020 | 1.39% |
| TANG CAPITAL MANAGEMENT LLC | 3,755,934 | $9,389,835 | 1.36% |
| Rubric Capital Management LP | 11,750,000 | $29,375,000 | 1.28% |
| Orchard Capital Management, LLC | 1,391,080 | $3,477,700 | 1.17% |
| JACOB ASSET MANAGEMENT OF NEW YORK LLC | 267,028 | $667,570 | 0.81% |
| CM Management, LLC | 250,000 | $625 | 0.75% |
| Tejara Capital Ltd | 493,619 | $1,234,048 | 0.71% |